that doesn't seem probable, not if you believe the 8-k zsan released couple weeks back. pk protocol hopefully submitted to fda by end of march, fda will review and give guidance or announce changes to protocol(which is great news, seems they want this approved) then pk study would begin, once study is completed I would think results submitted back to fda if everything looks good, remember this high plasma was with only 5 patients, then fda could give us a new pudfa date, i'm hoping worst case by years end and would love it quicker, hopefully lo's presentation on 9th will shed some light
